What are the side effects of Ozempic, and should users be concerned? Recent reports have highlighted alarming health risks associated with this widely used medication, particularly among those seeking to manage weight and type 2 diabetes.
Ozempic, primarily a GLP-1 medication, has gained popularity for its effectiveness in promoting weight loss. However, users are now urged to remain active despite the drug’s effects, as inactivity can exacerbate some of the negative consequences. A notable case involves a 63-year-old man who became legally blind after using Ozempic, developing a condition known as non-arteritic anterior ischemic optic neuropathy (NAION). He expressed regret, stating, “Had I known it could lead to sudden and permanent blindness, I never would have taken this drug,” highlighting the potential severity of its side effects.
Another concerning phenomenon linked to Ozempic is the condition referred to as “Ozempic face,” characterized by sagging skin and premature aging due to rapid weight loss. This condition has prompted a significant response from the cosmetic industry, with 60% of facial plastic surgeons reporting an increase in patients presenting with symptoms of “Ozempic Face.” Dr. Nidhi Rohatgi, a specialist in the field, advises, “Sudden quick fat loss impacts the overall body and skin in particular, so focus on reducing weight slowly and gradually.” This suggests that the rapid weight loss facilitated by Ozempic may have unintended consequences for users’ skin health.
In addition to skin issues, hair loss has also been reported as a side effect of GLP-1 drugs, occurring in approximately 3% of individuals in Wegovy clinical trials. As a result, users of Ozempic are increasingly seeking products to maintain skin elasticity and combat hair loss. The CEO of Ulta Beauty noted that GLP-1 users are actively looking for solutions to these emerging problems, reflecting a growing awareness of the drug’s side effects.
Financially, the impact of these side effects is evident in the beauty industry. Ulta Beauty reported annual sales of about $12.39 billion for 2025, with skincare, wellness, and hair care accounting for 43% of total sales. This indicates a strong market demand for products that address the aesthetic concerns arising from Ozempic usage. Furthermore, the CEO of Galderma reported a robust demand for facial fillers to counteract the sunken look in GLP-1 users, further emphasizing the cosmetic implications of the drug.
As Ozempic continues to be prescribed to an increasing number of individuals—currently about 10% of the U.S. population is on weight-loss drugs—the long-term effects of these medications remain a topic of concern. While many users experience significant weight loss, the associated side effects raise critical questions about the overall safety and efficacy of such treatments.
In summary, while Ozempic provides a pathway for weight loss and diabetes management, the emerging side effects, including severe health risks and cosmetic issues, cannot be overlooked. The medical community is urged to continue monitoring these developments closely, as users navigate the complexities of managing their health in light of these potential dangers.
